Table 2.
Full Sample, including cognitively healthy and participants with MCI N=349 | Subset of participants with MCI at baseline N=244 | |||||
---|---|---|---|---|---|---|
Predictor | OR | 95%CI | P-value | OR | 95%CI | P-value |
IICV alone | 2.39 | (1.60, 3.56) | <0.0001 | 2.77 | (1.72, 4.46) | <0.0001 |
Ratio of CSF p-tau181/Aβ42 alone | 2.13 | (1.52, 2.99) | <0.0001 | 2.16 | (1.49, 3.13) | <0.0001 |
IICV and CSF analytes together | - | - | - | - | - | - |
IICV | 2.81 | (1.83, 4.33) | <0.0001 | 3.41 | (2.03, 5.73) | <0.0001 |
Ratio of CSF p-tau181/Aβ42 | 2.48 | (1.72, 3.60) | <0.0001 | 2.63 | (1.73, 4.01) | <0.0001 |
Notes:
Base Model included baseline age, baseline education, APOE e4 status and years of follow-up. For analyses including cognitively healthy participants and those with MCI, base model also includes baseline diagnostic status.
IICV was estimated using baseline data.
Abbreviations:
MCI: Mild Cognitive Impairment
IICV: Intra-individual cognitive variability
CSF: Cerebrospinal fluid
OR: Odd ratio
CI: Confidence Interval